Skip to content

The Effect of Manual Lymphatic Drainage

Investigation of the Effect of Manual Lymphatic Drainag on Venous Ulcer Healing Rate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04461132
Enrollment
10
Registered
2020-07-08
Start date
2018-09-11
Completion date
2020-05-29
Last updated
2020-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphatic Disease, Venous Insufficiency, Venous Leg Ulcer

Brief summary

In venous ulcer, venous insufficiency is accompanied by lymphatic insufficiency. Manual lymphatic drainage (mld) technique cause to increase contraction rate of lymphatic collector and venous flow. It is known that Manual lymphatic drainage accelerates microcirculation, enabling nutrients and oxygen to reach tissues and at the same time removing residual substances from the tissue. We hypothesis that if we inrease to lypmhatic activity with MLD, we could stimulate healing of ulcer. The aim of this study to investigate the effect of manual lymphatic drainage on venous ulcer healing.

Interventions

MLD vith vodder technique was applied to leg

OTHERSkin Care

Wound was cleaned with salin and covered by dressing without including active products

OTHERExercise

breathing and foot pump exercise was prescribed

OTHERShame Manual Lymphatic drainage

manual lymphatic drainage was applied with light touch instead of real mld techniques

Sponsors

Istanbul Health Sciences University
CollaboratorUNKNOWN
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

prospective randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* with venous ulcer unhealing for at least 6 weeks * Without enfection * vascular surgery is not indicated * There is no obstruction to apply MLD and compression to lower extremty

Exclusion criteria

* with diabetic mellutus * with enfection * with ABI\<0,7 * Patients who have undergone venous vascular surgery * Patients undergoing active wound closure treatment

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of wound healingChange from baseline wound healing following the end of treatment (12. treatment session) and 1 month after the end of treatment.Wound was assesed by analyzing photographes of wound with Tracker software.
Evaluation of range of motion of ankleChange from baseline range of motion following the end of treatment (12. treatment session) and 1 month after the end of treatment.range of motion of ankle was measured with goniometer
Evaluation of painChange from baseline pain following the end of treatment (12. treatment session) and 1 month after the end of treatment.Pain was evaluated by Visual Analog Scale between 0 (no pain)-10 (extreme) pain.
evaluation of edemaChange from baseline edema following the end of treatment (12. treatment session) and 1 month after the end of treatment.edema was measured by 3D scanner
evaluation of quality of lifeChange from baseline quality of life following scores the end of treatment (12. treatment session) and 1 month after the end of treatment.quality of life was evaluated by SF- 12

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026